Related Experiment Video
Updated: Jul 19, 2026
06:08
Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
Published on: September 22, 2023
Local mucosal immunoglobulin E production: does allergy exist in non-allergic rhinitis?
1Division of Pathology, School of Molecular Medical Sciences, Queen's Medical Centre, Nottingham, UK. des.powe@nottingham.ac.uk
Summary
This review examines local allergic rhinitis and local allergy in non-atopic idiopathic rhinitis. Evidence for local IgE production in allergic rhinitis is assessed to understand non-allergic rhinitis pathways.
Area of Science:
- Immunology
- Otorhinolaryngology
Background:
- Allergic rhinitis pathways are well-studied, unlike non-allergic rhinitis.
- A hypothesis suggests local, tissue-specific allergies in the nasal mucosa of non-atopic individuals.
Purpose of the Study:
- To critically evaluate evidence for local IgE production in allergic rhinitis.
- To explore the concept of local allergy in non-atopic idiopathic rhinitis.
- To discuss detection methods and therapeutic strategies for non-allergic rhinitis.
Main Methods:
- Literature review and critical evaluation of existing studies.
- Analysis of evidence for local immunoglobulin E (IgE) production.
- Examination of therapeutic regimens for non-allergic rhinitis.
Main Results:
- Evidence for local IgE production in allergic rhinitis is a prerequisite for investigating non-allergic rhinitis.
- Fewer studies focus on non-allergic rhinitis disease pathways compared to allergic rhinitis.
- Therapeutic insights into non-allergic rhinitis pathophysiology are derived from successful treatments.
Conclusions:
- Understanding local IgE production is key to differentiating allergic and non-allergic rhinitis.
- Further research is needed into the pathophysiology of non-allergic rhinitis.
- Exploring local allergy concepts may reveal new diagnostic and therapeutic targets.
Related Concept Videos
02:06Allergic Reactions
Overview
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
00:42Cross-reactivity
Overview
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...